1994
DOI: 10.1093/bja/73.5.645
|View full text |Cite
|
Sign up to set email alerts
|

Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
49
0
1

Year Published

1997
1997
2021
2021

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 68 publications
(54 citation statements)
references
References 0 publications
3
49
0
1
Order By: Relevance
“…In such patients, the incidence of hyperfibrinolysis varies from 19% to 95% [6][7][8] and may contribute to serious bleeding complications. The pathogenesis of hyperfibrinolysis in liver cirrhosis is not yet clearly known.…”
Section: Discussionmentioning
confidence: 99%
“…In such patients, the incidence of hyperfibrinolysis varies from 19% to 95% [6][7][8] and may contribute to serious bleeding complications. The pathogenesis of hyperfibrinolysis in liver cirrhosis is not yet clearly known.…”
Section: Discussionmentioning
confidence: 99%
“…Most of these studies have failed to define, preoperatively, biological factors (specially those related to hemostatic disorders) predictive of hemorrhage. 1,[7][8][9][10] Surgical conditions such as experience of the team, use of specific coagulation devices and previous abdominal surgery have, more often, been blamed. 1,2 Moreover, the majority of these trials included various types of liver disease in the patient population under study, mixing acute and chronic cases.…”
Section: Méthode : Quatre Cent DIX Patients Successifs Ont Participé mentioning
confidence: 99%
“…For all these reasons, several attempts have been made to identify patients with a high risk of bleeding and to define preoperative factors which could influence intraoperative bleeding. 5,[7][8][9][10] Results have been contradictory, mainly because of non-homogenous patient selection, surgical conditions and intraoperative management. Our study focussed on chronic liver diseases and preoperative clotting data.…”
Section: Se (%) Sp (%) Ppv (%) Npv (%)mentioning
confidence: 99%
See 1 more Smart Citation
“…Protease inhibitors, such as aprotinin, ⑀-aminocaproic acid, and tranexamic acid, reduce hyperfibrinolysis and platelet dysfunction and have been found to reduce blood transfusion requirements in cardiac surgery with cardiopulmonary bypass 11 and liver surgery. [12][13][14][15][16][17] This effect on blood transfusion requirements can be achieved with no side effects in most patients. 18 Other factors such as the experience of the surgeon, improvements in surgical and anesthesiological techniques, venovenous bypass, and donor graft cold ischemia time are more likely to be important factors in intraoperative and/or postoperative blood loss than in intraoperative coagulation monitoring.…”
Section: Copyright 1997 By the American Association For The Study Of mentioning
confidence: 97%